SCHEMBL19637255

SCHEMBL19637255

CCc1c(C)nc(OC(C)C)nc1N(CC)CC

nearest known ligand 0.34

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 2/20 0.34
▸ MAPT P10636 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25021649 0.88 PDE10A (0.30) —
SCHEMBL19637369 0.80 HTT (0.35) HTT
SCHEMBL19637079 0.75 HTT (0.32) HTTMAPTHPGDTSHR
SCHEMBL19637432 0.72 KDM4E (0.36) —
SCHEMBL22994841 0.71 KDM4E (0.38) —
SCHEMBL22994752 0.69 KDM4E (0.35) MAPTHPGD
SCHEMBL21912065 0.68 KDM4E (0.34) MAPTHPGD
SCHEMBL19637172 0.67 HTT (0.32) HTT
SCHEMBL19636917 0.67 HRH3 (0.42) —
SCHEMBL19637446 0.67 KDM4E (0.36) MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3458445-B1 KRAS G12C INHIBITORS MIRATI THERAPEUTICS INC (US) 2021-02-17 — — EP disclosed
WO-2020055760-A1 COMBINATION THERAPIES Mirati Therapeutics, Inc. (US) 2020-03-19 — — WO disclosed
WO-2017201161-A1 KRAS G12C INHIBITORS Mirati Therapeutics, Inc. (US) 2017-11-23 — — WO disclosed
Send feedback